Assignee
RGENIX INC
US·7 granted patents·3 pending applications·29 citations·filing 2015–2020
Top patents by PatentIndex Score
10 records- 0193US9884813B1Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereofRGENIX INC·Filed 2017·Granted Feb 6, 2018·11 cites·28 claims
- 0290US9827217B2Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereofRGENIX INC·Filed 2016·Granted Nov 28, 2017·8 cites·18 claims
- 0389US11242407B2High-affinity anti-MERTK antibodies and uses thereofRGENIX INC·Filed 2020·Granted Feb 8, 2022·4 cites·37 claims
- 0487US10669296B2LXR agonists and uses thereofRGENIX INC·Filed 2015·Granted Jun 2, 2020·6 cites·19 claims
- 0562US2020138759A1Pharmaceutically acceptable salts of beta-guanidinopropionic acid with improved properties and uses thereofRGENIX INC·Filed 2019·Application pending·0 cites
- 0661US10512623B2Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereofRGENIX INC·Filed 2017·Granted Dec 24, 2019·0 cites·15 claims
- 0754US10717704B2Inhibitors of creatine transport and uses thereofRGENIX INC·Filed 2019·Granted Jul 21, 2020·0 cites·14 claims
- 0853US2017056352A1PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOFRGENIX INC·Filed 2016·Application pending·0 cites
- 0952US10308597B2Inhibitors of creatine transport and uses thereofRGENIX INC·Filed 2015·Granted Jun 4, 2019·0 cites·16 claims
- 1040US2019125745A1Treatment and diagnosis of cancerRGENIX INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RGENIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →